Podcast
Author(s):
We traveled to Charlottesville, Virginia for a State of the Science Summit on Advanced Non-Small Cell Lung Cancer. The conference spanned early-stage advances, established and emerging treatments for oncogenic-driven disease, chemotherapy, immunotherapy, and the role of radiation
We traveled to Charlottesville, Virginia for a State of the Science Summit on Advanced Non—Small Cell Lung Cancer. The conference spanned early-stage advances, established and emerging treatments for oncogenic-driven disease, chemotherapy, immunotherapy, and the role of radiation.
Vorasidenib Shows Consistent Efficacy With Manageable Safety in IDH1/2-Mutant Diffuse Glioma
Tovorafenib Leads to Durable Off-Treatment Responses in Pediatric BRAF-Altered R/R Low-Grade Glioma
NanO2 Plus Radiation/Temozolomide Is Under Exploration in Newly Diagnosed Glioblastoma
Dr Elder on the Initial Safety Profile of IGV-001 in Newly Diagnosed Glioblastoma
2 Commerce Drive
Cranbury, NJ 08512